Similarly, in a group of patients with WUS, which did not have a specific onset time, and in a group of patients that presented and were treated within 6 h after AIS occurrence, no significant difference was confirmed (p = 0.708 for GFAP, p = 0.08 for UCH-L1). This evidence concerns the gene UCHL1 and androgen insensitivity syndrome.